Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation - Dual versus triple antithrombotic therapy.
Jean Philippe ColletHolger ThielePublished in: European heart journal (2021)
Keyphrases
- atrial fibrillation
- end stage renal disease
- acute coronary syndrome
- ejection fraction
- newly diagnosed
- chronic kidney disease
- percutaneous coronary intervention
- prognostic factors
- heart failure
- peritoneal dialysis
- left atrial
- direct oral anticoagulants
- oral anticoagulants
- mesenchymal stem cells
- antiplatelet therapy
- venous thromboembolism
- patient reported outcomes
- mitral valve
- left ventricular
- patient reported